BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22723506)

  • 1. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
    Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
    Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to clinical trial participation by older women with breast cancer.
    Kemeny MM; Peterson BL; Kornblith AB; Muss HB; Wheeler J; Levine E; Bartlett N; Fleming G; Cohen HJ
    J Clin Oncol; 2003 Jun; 21(12):2268-75. PubMed ID: 12805325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
    Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
    Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.
    Kehl KL; Arora NK; Schrag D; Ayanian JZ; Clauser SB; Klabunde CN; Kahn KL; Fletcher RH; Keating NL
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment.
    Rieder SM; Burgess E; Rutledge T; Sussman A; Boyce T; Pankratz VS; Kano M
    Gynecol Oncol; 2024 May; 184():103-110. PubMed ID: 38301308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
    Canouï-Poitrine F; Lièvre A; Dayde F; Lopez-Trabada-Ataz D; Baumgaertner I; Dubreuil O; Brunetti F; Coriat R; Maley K; Pernot S; Tournigand C; Hagege M; Aparicio T; Paillaud E; Bastuji-Garin S
    Oncologist; 2019 Dec; 24(12):e1351-e1359. PubMed ID: 31324663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of participation in treatment decision-making by older breast cancer patients.
    Maly RC; Umezawa Y; Leake B; Silliman RA
    Breast Cancer Res Treat; 2004 Jun; 85(3):201-9. PubMed ID: 15111757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists.
    Siminoff LA; Zhang A; Colabianchi N; Sturm CM; Shen Q
    J Clin Oncol; 2000 Mar; 18(6):1203-11. PubMed ID: 10715289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
    Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
    J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
    Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
    Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with participation in breast cancer treatment clinical trials.
    Avis NE; Smith KW; Link CL; Hortobagyi GN; Rivera E
    J Clin Oncol; 2006 Apr; 24(12):1860-7. PubMed ID: 16622260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.
    Wong YN; Schluchter MD; Albrecht TL; Benson AB; Buzaglo J; Collins M; Flamm AL; Fleisher L; Katz M; Kinzy TG; Liu TM; Manne S; Margevicius S; Miller DM; Miller SM; Poole D; Raivitch S; Roach N; Ross E; Meropol NJ
    J Clin Oncol; 2016 Feb; 34(5):479-87. PubMed ID: 26700120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
    Kinney AY; Richards C; Vernon SW; Vogel VG
    Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.